Human Disease Blood Atlas - LAMTOR4 - The Human Protein Atlas

GENERAL INFORMATIONⁱ General description of the gene and the encoded protein(s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project.
Gene nameⁱ Official gene symbol, which is typically a short form of the gene name, according to HGNC.	LAMTOR4
Gene descriptionⁱ Full gene name according to HGNC.	Late endosomal/lysosomal adaptor, MAPK and MTOR activator 4
Predicted locationⁱ All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions. Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached. Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s). The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.	Intracellular

HUMAN PROTEIN ATLAS INFORMATION
Upregulated in disease (PEA)ⁱ A gene is classified as upregulated in a disease if the average concentration of all samples of that disease is significantly higher (adj P-value<0.05) than the average concentration of samples of all diseases as measured by PEA . For gender specific diseases the analysis includes only samples corresponding to the same gender from the other diseases.	Not analyzed
Disease prediction model (PEA)ⁱ The disease(s) the gene is associated with and able to predict according to glmnet prediction models. To be included the gene has to be upregulated according to differential expression analysis and have more than 50% overall importance as indicated by the prediction models.	Not analyzed

PEA - PROTEIN CONCENTRATIONS IN THE PAN-CANCER COHORTⁱ Relative plasma concentrations of proteins in blood from patients having different types of cancer measured by proximity extension assay (PEA).
Pan-cancer data not available.

MS - PROTEIN CONCENTRATIONS IN THE PAN-CANCER COHORTⁱ Plasma concentrations of proteins in blood from patients having different types of cancer measured by quantitative mass spectrometry (MS) using isotope dilution strategies based on the addition of recombinant protein fragment standards.
Pan-cancer data not available.